##EasyReadMore##

Wednesday, November 17, 2010

Reuters Health Report

If you are having trouble viewing this email or would like to view it in your web browser, CLICK HERE

 
Good Morning Pan, WED 17 Nov 2010 
 
Treatment zaps high blood pressure at the source
Errors kill 15,000 aged patients a month: study
Donated U.S. heart devices reused in India
Advisers recommend Human Genome lupus drug
Speech monitoring could track Parkinson's: study
U.S. study faults aggressive end-of-life cancer care
Heart scans show those most likely to need statins
UK starts world's first stroke stem cell trial
Drug fails to protect kidneys from X-ray dye
Prescribed drugs cause 3 pct of French car crashes

Treatment zaps high blood pressure at the source
November 17, 2010 09:10 AM ET
CHICAGO (Reuters) - A device that destroys nerves leading to the kidney safely lowered blood pressure in people with treatment-resistant hypertension, potentially offering a new option for millions of people who struggle to keep their disease in check, researchers said on Wednesday.

Full Article
Errors kill 15,000 aged patients a month: study
November 16, 2010 04:57 PM ET
WASHINGTON (Reuters) - Mistakes and unavoidable problems kill an estimated 15,000 elderly U.S. patients every month in hospitals, U.S. government investigators reported on Tuesday.

Full Article
Donated U.S. heart devices reused in India
November 16, 2010 05:54 PM ET
CHICAGO (Reuters) - Implanted cardiac defibrillators removed from American patients due to infection or upgrade are saving lives in India thanks to a U.S. doctor with a big heart.

Full Article
Advisers recommend Human Genome lupus drug
November 16, 2010 08:19 PM ET
ADELPHI, Maryland (Reuters) - The first new lupus treatment in half a century moved closer to U.S. approval on Tuesday as an advisory panel endorsed a potential blockbuster medicine from Human Genome Sciences Inc.

Full Article
Speech monitoring could track Parkinson's: study
November 16, 2010 07:42 PM ET
LONDON (Reuters) - The severity of Parkinson's disease symptoms could be monitored remotely by analyzing speech patterns, saving health authorities time and money and easing the burden on patients, scientists said Wednesday.

Full Article
U.S. study faults aggressive end-of-life cancer care
November 16, 2010 01:03 PM ET
WASHINGTON (Reuters) - One third of U.S. patients dying of cancer end up getting costly but futile treatment in hospitals, when hospice care to ease their suffering would be more appropriate, researchers reported on Tuesday.

Full Article
Heart scans show those most likely to need statins
November 16, 2010 04:49 PM ET
CHICAGO (Reuters) - A heart scan that checks for hardening of the arteries is a better way to predict who will benefit from cholesterol-fighting statin drugs, U.S. researchers said on Tuesday in a finding that could reduce the number of people who take statins.

Full Article
UK starts world's first stroke stem cell trial
November 16, 2010 11:52 AM ET
LONDON (Reuters) - Doctors in Scotland working with British biotech company ReNeuron have injected stem cells into the brain of a man in a pioneering clinical trial to test the safety of a therapy for patients disabled by stroke.

Full Article
Drug fails to protect kidneys from X-ray dye
November 16, 2010 12:27 PM ET
CHICAGO (Reuters) - A drug used to protect the kidneys from contrast dye during X-rays of the heart's blood vessels does not work, researchers said on Tuesday, citing a large study that may change the way patients are treated.

Full Article
Prescribed drugs cause 3 pct of French car crashes
November 16, 2010 11:37 AM ET
LONDON (Reuters Life!) - Prescribed drugs are responsible for more than three percent of road crashes in France and an international system should be agreed to warn of the risks of driving on medication, scientists said on Monday.

Full Article
 
 











REUTERS www.reuters.com
Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book.Details
Subscribe to other Reuters newsletters
Unsubscribe from this newsletter.


Forward to a friend Send this mailing to a friend or colleague


Reuters.com: Help and Contact Us | Advertise With Us | Mobile | Newsletters | RSS RSS Feed | Interactive TV | Labs | Reuters in Second Life | Archive | Site Index | Video Index

Thomson Reuters Corporate: Copyright | Disclaimer | Privacy | Professional Products | Professional Products Support | About Thomson Reuters | Careers

No comments:

Not What You Were Looking For? Try a new Google Web Search